Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-12T00:16:11.359Z.
Calculation as of: 2026-09-12T00:16:11.359Z.
Quote observation: 2026-09-11T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d1f0a601bf4881217105f3d38e84d63c1bd62d476e1a552230e61949490821d6
PEG RATIO
N/A
United Therapeutics Corporation
Market Cap
$21.10B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| United Therapeutics Corporation (UTHR) | $21.10B | N/A |
| STERIS plc (STE)vs › | $20.54B | N/A |
| Viatris Inc. (VTRS)vs › | $19.23B | N/A |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.09B | N/A |
| BioNTech SE (BNTX)vs › | $24.30B | N/A |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.37B | N/A |
| Incyte Corporation (INCY)vs › | $24.62B | N/A |
| Labcorp Holdings Inc. (LH)vs › | $25.55B | N/A |
| Medpace Holdings, Inc. (MEDP)vs › | $16.40B | N/A |
| Quest Diagnostics Incorporated (DGX)vs › | $25.94B | N/A |
PEG Ratio
N/A
P/E Ratio
17.8
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
